Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cellcura ASA Completes Private Placement-COMPLETE STORY
Cellcura ASA announced that it has on June 13, 2013 completed a private placement of 41,697,843 shares directed towards existing shareholders and Norwegian investors. The private placement, which represents a share capital increase of approximately 63%, was completed after the close of Oslo Stock Exchange. The subscription price was set by the board of directors at NOK 0.20 per share. The gross proceeds from the private placement will be NOK 8,339,569. The net proceeds from the private placement will be used for expenditures related to the development of the Company's projects and general corporate purposes. The private placement was managed by Magellan AS. The general meeting has resolved to conduct a subsequent offering of up to 125,000,000 new shares each with a nominal value of NOK 0.10. The subscription price will be NOK 0.20 per offer share. The subsequent offering will be directed towards the shareholders in CellCura as of close of the Oslo Stock Exchange on June 13, 2013 who did not participate in the private placement (the Eligible Shareholders). The Eligible Shareholders will be granted non-transferrable allocation rights corresponding with their pro rata ownership as per Record Date. Each allocation right gives the right to subscribe for, and be allocated, one offer share in the subsequent offering. The shares of CellCura will be traded exclusive the right to participate in the subsequent offering from and including June 14, 2013 (ex date).
Latest Developments for Cellcura ASA
Latest Key Developments in Medical
- Share this
- Digg this